Beta Bionics, Inc. Common Stock BBNX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $110.24M+10.0% | $100.25M+13.2% | $88.57M+13.5% | $78.02M+11.7% | $69.83M+7.2% | ||
| $47.24M+5.6% | $44.71M+11.0% | $40.29M+12.1% | $35.95M+11.7% | $32.17M+10.0% | ||
| $63M+13.4% | $55.54M+15.0% | $48.28M+14.7% | $42.08M+11.7% | $37.66M+4.9% | ||
| 57.2%+1.8pp | 55.4%+0.9pp | 54.5%+0.6pp | 53.9%0.0pp | 53.9%-1.2pp | ||
| $37.56M+8.0% | $34.79M+2.7% | $33.87M+9.9% | $30.82M+8.9% | $28.3M+8.1% | ||
| $68.74M+11.9% | $61.4M+9.9% | $55.87M+12.9% | $49.47M+15.5% | $42.83M+15.5% | ||
| $34.02M+9.7% | $31.03M+14.4% | $27.13M+11.6% | $24.31M+15.9% | $20.98M+17.4% | ||
| $140.31M+10.3% | $127.22M+8.8% | $116.88M+11.7% | $104.61M+13.6% | $92.1M+13.5% | ||
| -$77.31M-7.9% | -$71.68M-4.5% | -$68.59M-9.7% | -$62.53M-14.9% | -$54.44M-20.3% | ||
| -70.1%+1.4pp | -71.5%+5.9pp | -77.4%+2.7pp | -80.1%-2.2pp | -78%-8.5pp | ||
| —— | —— | -$9.25M+14.7% | -$10.84M+34.4% | -$16.52M-73.8% | ||
| -$66.44M+9.2% | -$73.2M+6.0% | -$77.84M-6.1% | -$73.37M-3.4% | -$70.96M-29.6% | ||
| -60.3%+12.7pp | -73%+14.9pp | -87.9%+6.1pp | -94%+7.6pp | -101.6%-17.5pp | ||
| -$1.50+22.7% | -$1.94+55.8% | -$4.39+20.5% | -$5.52+26.4% | -$7.50+13.2% | ||
| -$75.46M-7.6% | -$70.11M-4.1% | -$67.33M-9.8% | -$61.31M-15.1% | -$53.27M-20.8% | ||
| -68.4%+1.5pp | -69.9%+6.1pp | -76%+2.6pp | -78.6%-2.3pp | -76.3%-8.6pp | ||
| -$77.31M-7.9% | -$71.68M-4.5% | -$68.59M-9.7% | -$62.53M-14.9% | -$54.44M-20.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Beta Bionics, Inc. Common Stock's revenue?
- Beta Bionics, Inc. Common Stock (BBNX) generated $110.2M in revenue over the trailing twelve months, up 57.9% year over year.
- Is Beta Bionics, Inc. Common Stock profitable?
- Beta Bionics, Inc. Common Stock is not currently profitable: it reported a net loss of $66.4M over the trailing twelve months, a -60.3% net margin.
- What are Beta Bionics, Inc. Common Stock's profit margins?
- Gross margin is 57.2% and operating margin is -70.1%, with a -60.3% net margin.
- What is Beta Bionics, Inc. Common Stock's earnings per share?
- Beta Bionics, Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.50.
- Where does Beta Bionics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
